Rare diseases
Investigational molecules
Locations
Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
ItalyPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
ItalyEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
ItalyPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
ItalyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
ItalyA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
ItalyLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
ItalyStudy of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers
ItalyEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
ItalyFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
ItalyPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
ItalyA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
